[1]金宏伟，曾新华，黄河清. 蛋白质组技术研究人血清功能蛋白质的新进展[J]. 检验医学，2008，23（3）:327-330.[2]Williams KL，Gooley AA，Haynes PA，et al. Analy-tical biotechnology: applications for downstream processing[J]. Aust J Biotechnol，1991，5（2）:96-100.[3]Reddy KS，Perrotta PL. Proteomics in transfusion medicine[J]. Transfusion，2004，44（4）:601-604.[4]贾克刚，刘军锋，刘运德. 蛋白质组及其在心血管系统的研究进展[J]. 检验医学，2007，22（1）:88-90.[5]Brigulla M，Thiele T，Scharf C，et al. Proteomics as a tool for assessment of therapeutics in transfusion medicine: evaluation of prothrombin complex con-centrates[J]. Transfusion，2006，46（3）:377-385.[6]Clifton JG，Huang F，Kovac S，et al. Proteomic characterization of plasma-derived clotting factor Ⅷ-von Willebrand factor concentrates[J]. Electro-phoresis，2009，30（20）:3636-3646.[7]Clifton J，Huang F，Gaso-Sokac D，et al. Use of proteomics for validation of the isolation process of clotting factor Ⅸ from human plasma[J]. J Proteomics，2010，73（3）:678-688.[8]Steil L，Thiele T，Hammer E，et al. Proteomic characterization of freeze-dried human plasma: providing treatment of bleeding disorders without the need for a cold chain[J]. Transfusion，2008，48（11）:2356-2363.[9]Sidhu RS，Le T，Brimhall B，et al. Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1-6 degrees C for five days[J]. J Clin Apher，2006，21（4）:224-226.[10]Yazer MH，Cortese-Hassett A，Triulzi DJ. Coagulation factor levels in plasma frozen within 24 hours of phlebotomy over 5 days of storage at 1 to 6 degrees C[J]. Transfusion，2008，48（12）:2525-2530.[11]Von Heymann C，Keller MK，Spies C，et al. Activity of clotting factors in fresh-frozen plasma during storage at 4 degrees C over 6 days[J]. Transfusion，2009，49（5）:913-920.[12]Crettaz D，Sensebe L，Vu DH，et al. Proteomics of methylene blue photo-treated plasma before and after removal of the dye by an absorbent filter[J]. Proteomics，2004，4（3）:881-891.[13]Anniss AM，Glenister KM，Killian JJ，et al. Proteomic analysis of supernatants of stored red blood cell products[J]. Transfusion，2005，45（9）:1426-1433.[14]Bosman GJ，Lasonder E，Groenen-Dpp YA，et al. Comparative proteomics of erythrocyte aging in vivo and in vitro[J]. J Proteomics，2010，73（3）:396-402.[15]Bosman GJ，Lasonder E，Luten M，et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions[J]. Transfusion，2008，48（5）:827-835.[16]D′Amici GM，Rinalducci S，Zolla L. Proteomic analysis of RBC membrane protein degradation during blood storage[J]. J Proteome Res，2007，6（8）:3242-3255.[17]Rubin O，Crettaz D，Canellini G，et al. Micro-particles in stored red blood cells: an approach using flow cytometry and proteomic tools[J]. Vox Sang，2008，95（4）:288-297.[18]Bosman GJ，Stappers M，Novotny VM. Changes in band 3 structure as determinants of erythrocyte integrity during storage and survival after transfusion[J]. Blood Transfus，2010，8（Suppl 3）:s48-s52.[19]Power KA，McRedmond JP，de Stefani A，et al. High-throughput proteomics detection of novel splice isoforms in human platelets[J]. PLoS One，2009，4（3）:e5001.[20]Cagney G，McRedmond J. A central resource for platelet proteomics[J]. Arterioscler Thromb Vasc Biol，2008，28（7）:1214-1215.[21]Dittrich M，Birschmann I，Mietner S，et al. Platelet protein interactions:map，signaling components，and phosphorylation groundstate[J]. Arterioscler Thromb Vasc Biol，2008，28（7）:1326-1331.[22]Thiele T，Steil L，Gebhard S，et al. Profiling of alterations in platelet proteins during storage of platelet concentrates[J]. Transfusion，2007，47（7）:1221-1233.[23]Peter K. Proteomics unravels platelet function[J]. Blood，2010，115（20）:4008-4009.[24]Schulz C，Leuschen NV，Frhlich T，et al. Identification of novel downstream targets of platelet glycoprotein Ⅵ activation by differential proteome analysis: implications for thrombus formation[J]. Blood 2010，115（20）:4102-4110.
